Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes

By Nam J.-H.   Wyatt L.S.   Chae S.-L.   Cho H.-W.   Park Y.-K.   Moss B.  

Vaccine, Vol. 17, Iss. 3, 1999-02 ,pp. : 261-268

Elsevier

Access to resources Recommend Favorite

Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors

By Hodgson L.A.   Ludwig G.V.   Smith J.F.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1151-1160

Elsevier

Access to resources Recommend Favorite

A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model

By Morris-Downes M.M.   Sheahan B.J.   Fleeton M.N.   Liljestrom P.   Reid H.W.   Atkins G.J.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3877-3884

Elsevier

Access to resources Recommend Favorite

Passive immunization reduces immunity that results from simultaneous active immunization against tick-borne encephalitis virus in a mouse model

By Kreil T.R.   Burger I.   Attakpah E.   Olas K.   Eibl M.M.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 955-959

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus - poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

By Kanesa-thasan N.   Smucny J.J.   Hoke  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 483-491

Elsevier

Access to resources Recommend Favorite